Ondine Biomedical Inc (OBI) — Strategic Asset Allocation Index
Ondine Biomedical Inc (OBI) has a Strategic Asset Allocation Index of 28.1% as of June 2023. Strategic assets (PP&E of GBX1.16 Million plus long-term investments of GBX-) total GBX1.16 Million, measured against net assets of GBX4.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Ondine Biomedical Inc Strategic Asset Allocation Index (2006–2021)
This chart shows how Ondine Biomedical Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2006 to 2021. As of June 2023, the index stands at 28.1%, representing strategic assets of GBX1.16 Million against net assets of GBX4.14 Million GBX. Explore Ondine Biomedical Inc cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Ondine Biomedical Inc (2006–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Ondine Biomedical Inc from 2006 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Ondine Biomedical Inc (OBI) market capitalisation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 2.0% | GBX601.00K | GBX601.00K | GBX- | GBX29.66 Million | ▼ -171.3 pp |
| 2010 | 173.4% | GBX484.02K | GBX484.02K | GBX- | GBX279.19K | ▲ +138.1 pp |
| 2009 | 35.3% | GBX451.09K | GBX451.09K | GBX- | GBX1.28 Million | ▼ -13.4 pp |
| 2008 | 48.7% | GBX651.88K | GBX651.88K | GBX- | GBX1.34 Million | ▲ +39.6 pp |
| 2007 | 9.1% | GBX991.61K | GBX991.61K | GBX- | GBX10.84 Million | ▲ +4.3 pp |
| 2006 | 4.9% | GBX810.53K | GBX810.53K | GBX- | GBX16.59 Million | — |